User contributions
Jump to navigation
Jump to search
- 15:56, 5 September 2023 diff hist +77 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents
- 20:40, 2 September 2023 diff hist +480 m Neuroendocrine tumor →All lines of therapy Tag: visualeditor-switched
- 20:30, 2 September 2023 diff hist +836 Neuroendocrine tumor capecitabine & temozolomide for NET Tag: visualeditor-switched
- 23:45, 17 June 2021 diff hist +158 m Antiemesis Selinexor added to antiemetic table
- 21:01, 8 June 2021 diff hist +64 m Antiemesis lurbinectedine emetic risk added
- 15:58, 8 June 2021 diff hist +1 m Antiemesis formating
- 15:58, 8 June 2021 diff hist +283 m Antiemesis formating, addting drug indexes
- 15:47, 8 June 2021 diff hist +32 m Antiemesis formating antiemetic page
- 15:44, 8 June 2021 diff hist +91 m Antiemesis formating antiemetic page
- 22:19, 4 June 2021 diff hist +743 m Carcinoma of unknown primary Carboplatin & Paclitaxel 2019 regimen for CUP
- 21:07, 19 May 2021 diff hist -2 m User:Karine Karine bio update Tag: visualeditor
- 20:47, 19 May 2021 diff hist +751 m Urothelial carcinoma TROPHY-U-01 study evidence and reference
- 21:09, 14 May 2021 diff hist +1,298 Paroxysmal nocturnal hemoglobinuria iptacopan Lancet study regimen and reference
- 20:55, 14 May 2021 diff hist +91 m Paroxysmal nocturnal hemoglobinuria investigational agents for PNH Tag: visualeditor
- 20:48, 14 May 2021 diff hist +330 m Iptacopan (Fabhalta) Iptacopan drug index info continued
- 20:43, 14 May 2021 diff hist +962 N Iptacopan (Fabhalta) Iptacopan drug index info
- 20:30, 14 May 2021 diff hist +24 m Drug index iptacopan added to drug index
- 16:33, 14 May 2021 diff hist +453 Non-small cell lung cancer Paz-Ares 2021 new regimen, chemo part
- 16:24, 14 May 2021 diff hist +1,860 Non-small cell lung cancer Paz-Ares 2021 new regimen
- 14:52, 14 May 2021 diff hist 0 m Prostate cancer formating
- 14:50, 14 May 2021 diff hist +599 m Prostate cancer TITAN study final analysis reference
- 19:59, 13 May 2021 diff hist +459 Breast cancer, HER2-positive Tolaney 7 year update reference
- 20:16, 12 May 2021 diff hist +402 Urothelial carcinoma reference for RTOG 0524 Tag: visualeditor
- 20:06, 12 May 2021 diff hist +589 m Urothelial carcinoma paclitaxel RT Pham 2014
- 04:38, 8 May 2021 diff hist +58 m Cold agglutinin disease →Sutimlimab monotherapy: formating Tag: visualeditor
- 04:28, 8 May 2021 diff hist +215 Cold agglutinin disease Sutimlimab regimen NEJM 2021
- 04:15, 8 May 2021 diff hist -198 m Cold agglutinin disease removed sutimlimab from investigational agents
- 04:12, 8 May 2021 diff hist +449 Cold agglutinin disease Cold agglutinin disease new regimen with sutimlimab summary table
- 21:10, 30 April 2021 diff hist -201 m Antiemesis minor edit Tag: visualeditor
- 20:52, 30 April 2021 diff hist +22 m Antiemesis atezo update and drug index Tag: visualeditor
- 20:40, 30 April 2021 diff hist +24 m Antiemesis ado-trastuzumab and altretamine antiemetic updates Tag: visualeditor
- 20:27, 30 April 2021 diff hist +14 m Antiemesis atezolizumab emetic potential update Tag: visualeditor
- 20:38, 15 October 2020 diff hist +222 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents Tag: visualeditor
- 20:36, 15 October 2020 diff hist +110 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents: Olaparib Tag: visualeditor
- 23:39, 20 July 2020 diff hist -6 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: JMC Tag: visualeditor
- 23:36, 20 July 2020 diff hist +16 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: JMC Tag: visualeditor
- 22:08, 29 October 2019 diff hist +253 N Talk:Small cell lung cancer Caspian study
- 20:15, 6 September 2019 diff hist +63 m Antiemesis Pixantrone and Pembrolizumab emetic MASCC risk Tag: visualeditor
- 20:12, 6 September 2019 diff hist +61 m Antiemesis added new agents to main table and emetic risk by MASCC Tag: visualeditor
- 20:01, 6 September 2019 diff hist +32 m Antiemesis added trabectedine to table with emetic potential by MASCC Tag: visualeditor
- 19:54, 6 September 2019 diff hist 0 m Antiemesis MASCC 2019 updates Tag: visualeditor
- 19:51, 6 September 2019 diff hist +16 m Antiemesis MASCC 2019 changes Tag: visualeditor
- 02:57, 4 June 2019 diff hist -207 m Antiemesis →Olanzapine (OLN) containing regimen: Deleted changes Tag: visualeditor
- 02:55, 4 June 2019 diff hist +207 m Antiemesis Trying to start table formating for evidence Tag: visualeditor
- 02:36, 4 June 2019 diff hist +67 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: Jacobi medical center Tag: visualeditor
- 02:31, 4 June 2019 diff hist +17 m Acute myeloid leukemia Formating Wei 2019 Tag: visualeditor
- 02:27, 4 June 2019 diff hist +182 m Acute myeloid leukemia →Chemotherapy: AML loDAC venetoclax Wei 2019 update with venetoclax dose reduction Tag: visualeditor
- 23:08, 19 May 2019 diff hist +611 m Antiemesis Melphalan antiemesis with citation Tag: visualeditor
- 22:00, 19 May 2019 diff hist -95 m Antiemesis BMT allo antiemesis Tag: visualeditor
- 18:17, 19 May 2019 diff hist +94 m Antiemesis Allogeneic BMT conditioning Tag: visualeditor